Designing Clinical Trials to Assess Antiepileptic Drugs as Monotherapy: Difficulties and Solutions

By Perucca Emilio  

CNS Drugs, Vol. 22, Iss. 11, 2008-01 ,pp. : 917-938

Adis International

Access to resources Recommend Favorite

Application of Lipidomics to Assess Lipogenesis in Drug Development and Pre-Clinical Trials

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 5, 2012-04 ,pp. : 736-745

Bentham Science Publishers

Access to resources Recommend Favorite

Uncertainty in the Translation of Preclinical Experiments to Clinical Trials. Why do Most Phase III Clinical Trials Fail?

By  

Current Gene Therapy, Vol. 9, Iss. 5, 2009-01 ,pp. : 368-374

Bentham Science Publishers

Access to resources Recommend Favorite

How to Assess Sympathetic Nervous System Activity in Clinical Practice

By  

Current Clinical Pharmacology, Vol. 8, Iss. 3, 2013-01 ,pp. : 182-188

Bentham Science Publishers

Access to resources Recommend Favorite

Analysis of 312 studies of investigational medicinal products in healthy subjects to assess the impact of the European Union Clinical Trials Directive

By Malcolm B.   Steve W.  

International Journal of Pharmaceutical Medicine, Vol. 16, Iss. 4, 2002-08 ,pp. : 179-183

Adis International

Access to resources Recommend Favorite